Abbott’s fully-absorbing stent gets FDA nod

AbsorbOUS-heroAbbott’s resorbable coronary stent, Absorb, gained FDA regulatory approval today, the first for a fully-dissolving coronary stent. Designed to be fully resorbed by the body within three years of implantation, the device is intended to achieve the endpoint of a more natural vasculature than can be achieved with metal stents.


In July 2016, MedMarket Diligence is publishing, “Global Dynamics of Surgical and Interventional Cardiovascular Procedures, 2015-2022”, Report #C500.